Evolent Health Inc   (EVH)
Other Ticker:  
Price: $34.7200 $0.31 0.901%
Day's High: $35 Week Perf: 1.64 %
Day's Low: $ 34.00 30 Day Perf: 16.78 %
Volume (M): 1,635 52 Wk High: $ 36.70
Volume (M$): $ 56,778 52 Wk Avg: $29.96
Open: $34.42 52 Wk Low: $23.33

 Market Capitalization (Millions $) 3,859
 Shares Outstanding (Millions) 111
 Employees 3,500
 Revenues (TTM) (Millions $) 1,964
 Net Income (TTM) (Millions $) -113
 Cash Flow (TTM) (Millions $) 8
 Capital Exp. (TTM) (Millions $) 29

Evolent Health Inc
We are a market leader in the new era of value-based care, in which leading health systems and physician organizations, which we refer to as providers, as well as health plans, which we refer to as payers, are moving their business models from traditional fee-for-service reimbursement to an increasingly integrated clinical and financial responsibility for populations. We refer to our provider and payer customers as partners. We consider this integration of health care delivery and financial responsibility with the aim of lowering cost, enhancing quality, and improving satisfaction, to be the core of value-based care. We believe the pace of this integration is accelerating, driven by price pressure in traditional FFS health care, a market environment that is incentivizing value-based care models, growth in consumer-focused insurance programs, such as Medicare Advantage and innovation in data and technology.
Our Evolent Health Services segment includes our integrated value based care platform designed to help our customers manage and administer patient health in a more cost-effective manner. Upon the acquisitions in 2016 of Valence Health and Aldera, we have invested to upgrade the platform and integrate it with Identifi' and our clinical solutions to create an integrated value-based care platform.

Health plan services: Health plan services is a comprehensive suite of services including third-party administration, enrollment and billing support, medical and utilization management, third-party payment and program integrity support and provider network contracting services. Other health plan related services include sales and marketing, product development, actuarial, and regulatory and compliance.
Pharmacy benefit management: Our team of professionals support the prescription drug component of providers' plan offerings and bring national buying power and dedicated resources that are tightly integrated with the care delivery model. Differentiated from what we consider to be traditional PBMs, our solution is integrated into patient care and engages population health levers including generic utilization, provider management, and utilization management to reduce pharmacy costs.
Risk management: Our risk management services provide the capabilities needed to successfully manage risk for payers, including analysis, data and operational integration with payer processes, and ongoing performance management.
Analytics and reporting: Our analytics and reporting services provide the ongoing and ad hoc analytic teams and reports required to measure, inform and improve performance, including population health analytics, market analytics, network evaluation, staffing models, physician effectiveness, clinical delivery optimization and patient engagement.
Leadership and management: Our local and national talent assist our partners in effectively managing the performance of their value-based operations.
Our Clinical Solutions segment has two primary solutions: (1) specialty care management services, and (2) total cost of care management. From time to time, we package our solutions under various go-to-market brand names to create product differentiation. Our partners may engage us to provide one type of solution, or multiple types of solutions, depending on specific needs.
Core elements of our total cost of care management services include: (1) population health performance, which supports the delivery of patient-centric cost effective care and (2) delivery network alignment, comprising the development of high performance delivery networks. Our total cost of care solution focuses on primary care providers, who serve as the primary point of contact for populations accessing medical care.
Our specialty care management services support a broad range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics. We focus on the oncology and cardiology markets with the objective of helping providers and payers deliver higher quality, more affordable care and we provide comprehensive quality management for oncology and cardiology patients from diagnosis through advance care planning services.

   Company Address: 1812 N. Moore Street Arlington 22209 VA
   Company Phone Number: 389-6000   Stock Exchange / Ticker: NYSE EVH


Stock Performances by Major Competitors

5 Days Decrease / Increase
HCAT   -0.72%    
PINC   -3.61%    
IBM        4.43% 
PRVA   -0.32%    
• View Complete Report

Evolent Health Inc

Evolent Health Inc Surges Ahead with Impressive Revenue Growth in Fourth Quarter of 2023

Despite reporting a deficit per share in the fourth quarter of 2023, Evolent Health Inc has shown tremendous growth in revenue, outperforming its industry competitors. The company's revenue surged by an impressive 45.4% compared to the same period last year, reaching $556.06 million. This strong growth in revenue is a clear indication of the company's success and potential for future expansion.
Furthermore, Evolent Health Inc's increase in accounts receivable suggests a rising demand for its services, which bodes well for its future financial performance. The company's net deficit may have widened compared to the previous year, but this can be attributed to the investments it has made in expanding its operations and enhancing its services.

Evolent Health Inc

Evolent Health Inc's Surging Revenue Fails to Bring Profitability, Raising Concerns for the Future

In the third quarter of the 2023 earnings season, Evolent Health Inc, an Internet Services & Social Media company, experienced mixed financial results. While the company saw a significant surge in revenue, its losses per share extended. This article will examine Evolent Health's performance in the context of the industry and provide insights into the company's future outlook.
Revenue Growth Outpaces Peers
Evolent Health Inc reported a remarkable revenue increase of 44.934% to $511.02 million compared to the corresponding period last year. This surge in revenue outpaced almost all other entities in the Internet Services & Social Media sector, which reported an average top-line improvement of 14.31%. Evolent Health's ability to achieve such substantial growth indicates its strong positioning in the market and effective revenue generation strategies.

Evolent Health Inc

Evolent Health Inc Reports Impressive 46.633% Q2 Revenue Spike, Outperforms Internet Services & Social Media Sector in 2023

In the second quarter of 2023, Evolent Health Inc, an Internet Services & Social Media company, experienced a significant surge in revenue by 46.633% to $469.14 million compared to the same quarter in the previous year. However, the company also saw an increase in its loss per share, with a reported figure of $-0.37 per share. This article aims to analyze Evolent Health Inc's financial results, taking into consideration its revenue growth, net loss, and market performance.
Revenue Growth Outperforms Sector Contemporaries:
Evolent Health's revenue surge in the second quarter of 2023 is indeed commendable, especially when compared to its competitors within the Internet Services & Social Media sector. The sector, as a whole, witnessed an overall revenue improvement of 8.25% during the same period. This demonstrates Evolent Health's ability to outperform its contemporaries, showcasing its strong market position and competitive advantage.

Evolent Health Inc

Evolent Health Inc Surges with Impressive Top-line Growth in Q1 2023, Dominating the Internet Services & Social Media Industry

Evolent Health Inc Records Net Loss of $-34 Million, ROE Dips to -3.92%
Investors in Evolent Health Inc will be disappointed to learn that the company recorded a cumulative net loss of $-34 million during the 12 months ending in the first quarter of 2023.
This resulted in a negative return on equity (ROE) of -3.92%, which is far from ideal for shareholders.
It's worth noting that within the Internet Services & Social Media industry, 11 other companies had a higher return on equity, indicating that there is significant competition in this space. Additionally, the company's total ranking has deteriorated compared to the fourth quarter of 2022, dropping from 0 to 1081.


Evolent Health Inc's Segments
• View Complete Report
  Company Estimates  
  Revenue Outlook
Evolent Health Inc does not provide revenue guidance.

Earnings Outlook
Evolent Health Inc does not provide earnings estimates.

Geographic Revenue Dispersion


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com